Sutton Wealth Advisors Inc. Bristol Myers Squibb CO Transaction History

Sutton Wealth Advisors Inc.

$203 Billion
Q3 2023

A detailed history of Sutton Wealth Advisors Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sutton Wealth Advisors Inc. holds 9,790 shares of BMY stock, worth $570,071. This represents 0.28% of its overall portfolio holdings.

Number of Shares

9,790

Previous 9,706 0.87%

Holding current value

$570,071

Previous $621 Million 8.46%

% of portfolio

0.28%

Previous 0.3%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$57.89 - $64.73 $4,862 - $5,437	84 Added 0.87%	9,790 $568 Million
Q2 2023 Nov 08, 2023	BUY	$63.71 - $70.74 $8,919 - $9,903	140 Added 1.46%	9,706 $621 Million
Q1 2023 Nov 07, 2023	SELL	$65.71 - $74.53 $150,147 - $170,301	-2,285 Reduced 19.28%	9,566 $663 Million
Q4 2022 Nov 07, 2023	BUY	$68.48 - $81.09 $7,806 - $9,244	114 Added 0.97%	11,851 $853 Million
Q3 2022 Nov 07, 2023	SELL	$0.13 - $76.84 $7 - $4,226	-55 Reduced 0.47%	11,737 $834 Million
Q2 2022 Nov 07, 2023	BUY	$72.62 - $79.98 $4,865 - $5,358	67 Added 0.57%	11,792 $908 Million
Q1 2022 Nov 07, 2023	BUY	$61.48 - $73.72 $4,180 - $5,012	68 Added 0.58%	11,725 $856 Million
Q4 2021 Nov 07, 2023	SELL	$53.63 - $62.52 $3,646 - $4,251	-68 Reduced 0.58%	11,657 $727 Million
Q3 2021 Nov 07, 2023	BUY	$59.17 - $69.31 $650 - $762	11 Added 0.09%	11,725 $694 Million
Q2 2021 Nov 07, 2023	SELL	$61.91 - $67.42 $742 - $809	-12 Reduced 0.1%	11,714 $783 Million
Q1 2021 Nov 07, 2023	BUY	$59.34 - $66.74 $1,186 - $1,334	20 Added 0.17%	11,726 $740 Million
Q4 2020 Nov 07, 2023	BUY	$57.74 - $65.43 $2,251 - $2,551	39 Added 0.33%	11,706 $726 Million
Q3 2020 Nov 07, 2023	BUY	$57.43 - $63.64 $6,202 - $6,873	108 Added 0.93%	11,667 $703 Million
Q2 2020 Nov 07, 2023	SELL	$54.82 - $64.09 $164 - $192	-3 Reduced 0.03%	11,559 $680 Million
Q1 2020 Nov 07, 2023	BUY	$46.4 - $67.43 $649 - $944	14 Added 0.12%	11,562 $644 Million
Q4 2019 Nov 07, 2023	BUY	$49.21 - $64.19 $7,922 - $10,334	161 Added 1.41%	11,548 $741 Million
Q3 2019 Nov 07, 2023	SELL	$42.77 - $50.71 $7,570 - $8,975	-177 Reduced 1.53%	11,387 $577 Million
Q2 2019 Nov 06, 2023	SELL	$44.62 - $49.34 $2,007 - $2,220	-45 Reduced 0.39%	11,564 $524 Million
Q1 2019 Nov 06, 2023	BUY	$45.12 - $53.8 $1,218 - $1,452	27 Added 0.23%	11,609 $554 Million
Q4 2018 Nov 06, 2023	BUY	$48.76 - $63.23 $357,313 - $463,349	7,328 Added 172.26%	11,582 $602 Million
Q2 2017 Nov 06, 2023	SELL	N/A	-12 Reduced 0.28%	4,254 $237 Million
Q4 2016 Nov 06, 2023	SELL	N/A	-47 Reduced 1.09%	4,266 $249 Million
Q3 2016 Nov 06, 2023	SELL	N/A	-689 Reduced 13.77%	4,313 $233 Million
Q2 2016 Nov 06, 2023	SELL	N/A	-326 Reduced 6.12%	5,002 $368 Million
Q1 2016 Nov 06, 2023	BUY	N/A	5,328	5,328 $340 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.

Account

Sutton Wealth Advisors Inc. Bristol Myers Squibb CO Transaction History